Now Reading
Biogen Leads From the Top With Disability Inclusion
Biogen Leads From the Top With Disability Inclusion
Published 12-03-21
Submitted by Biogen
December 3rd marks International Day of Persons with Disabilities, and we are glad to share that Biogen CEO Michel Vounatsos recently signed the Disability:IN’s CEO Letter on Disability Inclusion. We are proud we scored 100% on the Disability Equality Index for four consecutive years. We look forward to continued learning and growth to best support people with disabilities both within and outside of Biogen.
Learn more about our commitment for an accessible, inclusive workplace for all
Biogen
Biogen
Founded in 1978, Biogen is a leading global biotechnology company that has pioneered multiple breakthrough innovations including a broad portfolio of medicines to treat multiple sclerosis, the first approved treatment for spinal muscular atrophy, and two co-developed treatments to address a defining pathology of Alzheimer’s disease. Biogen is advancing a pipeline of potential novel therapies across neurology, neuropsychiatry, specialized immunology and rare diseases and remains acutely focused on its purpose of serving humanity through science while advancing a healthier, more sustainable and equitable world.
More from Biogen
